RYTM FY 2021 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RYTMRhythm Pharmaceuticals, Inc.

$6B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$3M81.0% margin

Operating Income

-$170M-5391.9% margin

Net Income

-$70M-2207.1% margin

EPS (Diluted)

$-1.37

Cash Flow

Operating Cash Flow

-$146M

Free Cash Flow

-$151M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$330M

Total Liabilities

$45M

Stockholders' Equity

$284M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$3M	-$690,000	+470.3%
Operating Income	-$170M	-$137M	-24.5%
Net Income	-$70M	-$131M	+46.8%